Clinical observation of re-bleeding after endoscopic treatment of GOV2 type gastric fundal varices
JIAO Chenyang
FU Yiwei
ZHAO Zhibin
Abstract：Objective To summarize the clinical characteristics of re-bleeding after endoscopic treatment of GOV2-type gastric varices.Methods A retrospective analysis was conducted on 28 patients who experienced re-bleeding after endoscopic treatment of GOV2-type gastric varices and were treated in the Department of Gastroenterology at Taizhou People's Hospital,Affiliated with Nanjing Medical University,from January 2019 to December 2022.The study examined the causes of bleeding,treatment methods and prognosis.Results Among the 28 patients,22(78.6％)had liver cirrhosis due to hepatitis B,3(10.7％)had primary biliary cirrhosis,2(7.1％)had autoimmune hepatitis with cirrhosis,and 1(3.6％)had alcoholic cirrhosis.The median time to re-bleeding after the initial endoscopic procedure was 41(34,89)days.The bleeding causes were gastric variceal bleeding in 24 patients(85.7％)and rupture of newly developed gastric varices in 4 patients(14.3％).Three patients(10.7％)showed improvement after conservative drug therapy,while 25 patients(89.3％)underwent endoscopic injection therapy,five of whom(17.9％)experienced fatal bleeding after endoscopic injection therapy.Conclusion Re-bleeding after endoscopic treatment of GOV 2-type gastric varices is associated with a high mortality rate,with gastric variceal bleeding,especially from gastroesophageal varices,being the most common cause.Timely endoscopic treatment is essential.
Keywords：gastric varicestissue adhesivelauromacrogolendoscopic therapy
Publication Date：2024-08-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 33-35,47 )